Frontiers in Aging Neuroscience | Alzheimer's Disease and Related Dementias

Brief Research Report

Published on 03 Nov 2023

Low bone mineral density is associated with gray matter volume decrease in UK Biobank

in Alzheimer's Disease and Related Dementias

Polona Kalc
Robert Dahnke
Felix Hoffstaedter
Christian Gaser

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1287304

4,159 views
8 citations

Original Research

Published on 03 Nov 2023

Automatic MRI volumetry in asymptomatic cases at risk for normal pressure hydrocephalus

in Alzheimer's Disease and Related Dementias

Sven Haller
Marie-Louise Montandon
Cristelle Rodriguez
François R. Herrmann
Panteleimon Giannakopoulos

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1242158

3,068 views
1 citation

Original Research

Published on 03 Nov 2023

An explainable machine learning based prediction model for Alzheimer's disease in China longitudinal aging study

in Alzheimer's Disease and Related Dementias

Ling Yue
Wu-gang Chen
Sai-chao Liu
Sheng-bo Chen
Shi-fu Xiao

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1267020

6,000 views
14 citations

Original Research

Published on 02 Nov 2023

Effects of the multidomain intervention with nutritional supplements on cognition and gut microbiome in early symptomatic Alzheimer’s disease: a randomized controlled trial

in Alzheimer's Disease and Related Dementias

Eun Hye Lee
Geon Ha Kim
Hee Kyung Park
Hae Jin Kang
Yoo Kyoung Park
Hye Ah Lee
Chang Hyung Hong
So Young Moon
Woorim Kang
Hyun-Seok Oh

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1266955

8,145 views
10 citations

Review

Published on 02 Nov 2023

Proteostasis and neurodegeneration: a closer look at autophagy in Alzheimer's disease

in Alzheimer's Disease and Related Dementias

Haleh Barmaki
Alireza Nourazarian
Fatemeh Khaki-Khatibi

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1281338

8,734 views
51 citations

Original Research

Published on 31 Oct 2023

Piecing it together: atrophy profiles of hippocampal subfields relate to cognitive impairment along the Alzheimer’s disease spectrum

in Alzheimer's Disease and Related Dementias

Nicholas J. Christopher-Hayes
Christine M. Embury
Alex I. Wiesman
Pamela E. May
Mikki Schantell
Craig M. Johnson
Sara L. Wolfson
Daniel L. Murman
Tony W. Wilson

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1212197

3,712 views
6 citations

Correction

Published on 31 Oct 2023

Corrigendum: Research trends and hotspots of glial fibrillary acidic protein within the area of Alzheimer's disease: a bibliometric analysis

in Alzheimer's Disease and Related Dementias

Yutong Zou
Lei Li
Lihua Guan
Chaochao Ma
Songlin Yu
Xiaoli Ma
Chenhui Mao
Jing Gao
Ling Qiu

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1312361

2,225 views

Brief Research Report

Published on 31 Oct 2023

APOE genotype and sex modulate Alzheimer’s disease pathology in aged EFAD transgenic mice

in Alzheimer's Disease and Related Dementias

Deebika Balu
Ana C. Valencia-Olvera
Zarak Islam
Clare Mielczarek
Allison Hansen
Tamara M. Perez Ramos
Jason York
Mary Jo LaDu
Leon M. Tai

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1279343

4,236 views
13 citations

Original Research

Published on 30 Oct 2023

The preservation of right cingulum fibers in subjective cognitive decline of preclinical phase of Alzheimer’s disease

in Alzheimer's Disease and Related Dementias

Yu Sun
Yanan Qiao
Jing Guo
Wenjie Hou
Yaojing Chen
Dantao Peng

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1223697

2,449 views
1 citation

Original Research

Published on 26 Oct 2023

An interpretable Alzheimer’s disease oligogenic risk score informed by neuroimaging biomarkers improves risk prediction and stratification

in Alzheimer's Disease and Related Dementias

Erica H. Suh
Garam Lee
Sang-Hyuk Jung
Zixuan Wen
Jingxuan Bao
Kwangsik Nho
Heng Huang
Christos Davatzikos
Andrew J. Saykin
Paul M. Thompson

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1281748

4,868 views
4 citations

Review

Published on 25 Oct 2023

Emerging Alzheimer’s disease therapeutics: promising insights from lipid metabolism and microglia-focused interventions

in Alzheimer's Disease and Related Dementias

Nour S. Tobeh
Kimberley D. Bruce

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1259012

11,458 views
28 citations

Original Research

Published on 24 Oct 2023

Association between cerebrospinal fluid clusterin and biomarkers of Alzheimer’s disease pathology in mild cognitive impairment: a longitudinal cohort study

in Alzheimer's Disease and Related Dementias

Hao Wang
Ling-Zhi Ma
Ze-Hu Sheng
Jia-Yao Liu
Wei-Yu Yuan
Fan Guo
Wei Zhang
Lan Tan

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1256389

4,659 views
7 citations

Systematic Review

Published on 23 Oct 2023

Systematic review and meta-analysis of the effects of menopause hormone therapy on risk of Alzheimer’s disease and dementia

in Alzheimer's Disease and Related Dementias

Matilde Nerattini
Steven Jett
Caroline Andy
Caroline Carlton
Camila Zarate
Camila Boneu
Michael Battista
Silky Pahlajani
Susan Loeb-Zeitlin
Yelena Havryulik

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1260427

48,444 views
71 citations

Review

Published on 20 Oct 2023

Shared genetic architecture of COVID-19 and Alzheimer’s disease

in Alzheimer's Disease and Related Dementias

Natalia Matveeva
Ivan Kiselev
Natalia Baulina
Ekaterina Semina
Viktor Kakotkin
Mikhail Agapov
Olga Kulakova
Olga Favorova

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1287322

5,841 views
11 citations

Review

Published on 19 Oct 2023

Alzheimer’s disease: an axonal injury disease?

in Alzheimer's Disease and Related Dementias

Liang Dan
Zhaohui Zhang

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1264448

9,569 views
13 citations

Original Research

Published on 18 Oct 2023

Bayesian workflow for the investigation of hierarchical classification models from tau-PET and structural MRI data across the Alzheimer’s disease spectrum

in Alzheimer's Disease and Related Dementias

Clyde J. Belasso
Zhengchen Cai
Gleb Bezgin
Tharick Pascoal
Jenna Stevenson
Nesrine Rahmouni
Cécile Tissot
Firoza Lussier
Pedro Rosa-Neto
Jean-Paul Soucy

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1225816

3,233 views
5 citations

Original Research

Published on 18 Oct 2023

Altered local and remote functional connectivity in mild Alzheimer’s disease patients with sleep disturbances

in Alzheimer's Disease and Related Dementias

Lei Wang
Rui Zhu
Xiao Zhou
Zhiyong Zhang
Dantao Peng

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1269582

2,943 views
4 citations

Original Research

Published on 18 Oct 2023

Systematic analysis of cuproptosis-related genes in immunological characterization and predictive drugs in Alzheimer’s disease

in Alzheimer's Disease and Related Dementias

Bin Nie
Yefen Duan
Xuelong Xie
Lihua Qiu
Shaorui Shi
Zhili Fan
Xuxiang Zheng
Ling Jiang

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1204530

3,262 views
5 citations

Original Research

Published on 16 Oct 2023

Unraveling the connection between gut microbiota and Alzheimer’s disease: a two-sample Mendelian randomization analysis

in Alzheimer's Disease and Related Dementias

Huiqiong Zeng
Kaixia Zhou
Yu Zhuang
Aidong Li
Baiwei Luo
Ye Zhang

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1273104

6,799 views
13 citations

Original Research

Published on 13 Oct 2023

Sex-specific relationship between non-alcoholic fatty liver disease and amyloid-β in cognitively unimpaired individuals

in Alzheimer's Disease and Related Dementias

Sung Hoon Kang
Heejin Yoo
Bo Kyoung Cheon
Jun Pyo Kim
Hyemin Jang
Hee Jin Kim
Mira Kang
Kyungmi Oh
Seong-Beom Koh
Duk L. Na

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1277392

4,281 views
4 citations

Original Research

Published on 12 Oct 2023

Clinical effects of novel susceptibility genes for beta-amyloid: a gene-based association study in the Korean population

in Alzheimer's Disease and Related Dementias

Bo-Hyun Kim
HyunWoo Lee
Hongki Ham
Hee Jin Kim
Hyemin Jang
Jun Pyo Kim
Yu Hyun Park
Mansu Kim
Sang Won Seo

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1278998

3,799 views
7 citations

Systematic Review

Published on 12 Oct 2023

Cardiovascular disease risk models and dementia or cognitive decline: a systematic review

in Alzheimer's Disease and Related Dementias

Ruirui Jia
Qing Wang
Hengyi Huang
Yanli Yang
Yuet Foon Chung
Tao Liang

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1257367

8,884 views
24 citations

Study Protocol

Published on 12 Oct 2023

Study on the effect of 40 Hz non-invasive light therapy system. A protocol for a randomized, double-blinded, placebo-controlled clinical trial

in Alzheimer's Disease and Related Dementias

Mikkel Pejstrup Agger
Maibritt Horning
Marcus Schultz Carstensen
Else Rubæk Danielsen
Anders Olhues Baandrup
Mai Nguyen
Peter Høgh
Kamilla Miskowiak
Paul Michael Petersen
Kristoffer Hougaard Madsen

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1250626

14,982 views
3 citations

Original Research

Published on 12 Oct 2023

Genetic background influences the 5XFAD Alzheimer's disease mouse model brain proteome

in Alzheimer's Disease and Related Dementias

Cheyenne D. Hurst
Amy R. Dunn
Eric B. Dammer
Duc M. Duong
Sarah M. Shapley
Nicholas T. Seyfried
Catherine C. Kaczorowski
Erik C. B. Johnson

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1239116

4,698 views
8 citations

2,200 articles

articles

Low bone mineral density is associated with gray matter volume decrease in UK Biobank

Automatic MRI volumetry in asymptomatic cases at risk for normal pressure hydrocephalus

An explainable machine learning based prediction model for Alzheimer's disease in China longitudinal aging study

Effects of the multidomain intervention with nutritional supplements on cognition and gut microbiome in early symptomatic Alzheimer’s disease: a randomized controlled trial

Proteostasis and neurodegeneration: a closer look at autophagy in Alzheimer's disease

Piecing it together: atrophy profiles of hippocampal subfields relate to cognitive impairment along the Alzheimer’s disease spectrum

Corrigendum: Research trends and hotspots of glial fibrillary acidic protein within the area of Alzheimer's disease: a bibliometric analysis

APOE genotype and sex modulate Alzheimer’s disease pathology in aged EFAD transgenic mice

The preservation of right cingulum fibers in subjective cognitive decline of preclinical phase of Alzheimer’s disease

An interpretable Alzheimer’s disease oligogenic risk score informed by neuroimaging biomarkers improves risk prediction and stratification

Emerging Alzheimer’s disease therapeutics: promising insights from lipid metabolism and microglia-focused interventions

Association between cerebrospinal fluid clusterin and biomarkers of Alzheimer’s disease pathology in mild cognitive impairment: a longitudinal cohort study

Systematic review and meta-analysis of the effects of menopause hormone therapy on risk of Alzheimer’s disease and dementia

Shared genetic architecture of COVID-19 and Alzheimer’s disease

Alzheimer’s disease: an axonal injury disease?

Bayesian workflow for the investigation of hierarchical classification models from tau-PET and structural MRI data across the Alzheimer’s disease spectrum

Altered local and remote functional connectivity in mild Alzheimer’s disease patients with sleep disturbances

Systematic analysis of cuproptosis-related genes in immunological characterization and predictive drugs in Alzheimer’s disease

Unraveling the connection between gut microbiota and Alzheimer’s disease: a two-sample Mendelian randomization analysis

Sex-specific relationship between non-alcoholic fatty liver disease and amyloid-β in cognitively unimpaired individuals

Clinical effects of novel susceptibility genes for beta-amyloid: a gene-based association study in the Korean population

Cardiovascular disease risk models and dementia or cognitive decline: a systematic review

Study on the effect of 40 Hz non-invasive light therapy system. A protocol for a randomized, double-blinded, placebo-controlled clinical trial

Genetic background influences the 5XFAD Alzheimer's disease mouse model brain proteome